Agilisium, A
Leading Autonomous Agentic AI Partner To The Life Sciences Industry, Celebrates
A Decade of Innovation with a Grand Gesture; Gifts Hyundai Creta Cars To All
Its Long-Serving Employees.
~In a
challenging business environment currently navigating cost optimizations and
widespread freezes, Agilisium has stood apart by awarding performance hikes
this year, reinforcing its people-first culture even amid headwinds~
Chennai, 12th June, 2025: In a grand gesture of shared success, Agilisium, a leading autonomous Agentic AI partner to Life Sciences industry, today honoured the unwavering commitment and contributions of its long-serving employees by gifting brand new Hyundai Creta SUVs. Fostering a culture that values and celebrates shared success, this initiative, organized as part of its 10th year anniversary, recognized 25 employees, who have been instrumental in shaping the company’s journey from inception to global scale in its first decade, exemplifying its deep-rooted commitment to valuing employees.
The
milestone moment was celebrated with a spectacular event at Agilisium’s
headquarters in the World Trade Center, Chennai, where over 500 employees gathered
for what was expected to be an employee get-together.
In a beautifully
orchestrated surprise, the employees and their family members were greeted by a
fleet of brand-new Hyundai Creta SUVs, turning the corporate celebration into
an unforgettable emotional moment. The company, as part of its people-first
philosophy, despite headwinds in the business environment, also announced
performance hikes to its employees across levels.
Speaking at the commemorative event, Mr. Raj Babu, Founder and CEO of Agilisium, said, “At Agilisium, we have always believed that our people are our strongest differentiator. Even in a year when industry has taken a cautious stance, we chose to invest in our talent through timely hikes and meaningful recognition. These cars are not rewards; they are a symbol of enduring trust, shared purpose, and the spirit of building something remarkable together. From day one, these team members believed in Agilisium’s vision when it was just an idea taking shape.
They’ve not only
stood by it, but shaped it, helping take the company from a startup with
ambition to a global partner in Life Sciences AI. In a year when much of the
industry is holding back, we’ve chosen to step forward recognizing that
sustainable growth is built on the loyalty, belief and commitment of people.
These cars are a small token of our immense gratitude.”
During the event, the
company also unveiled its future roadmap under its renewed vision ‘Agilisium
3.0’ rooted in Business Impact through Autonomous Agentic AI. The
renewed vision is focused on helping Life Sciences organizations drive
innovation, improve patient outcomes, and unlock business transformation at
scale. With marquee clients in the Life Sciences sector and a rapidly expanding
presence in the US, Europe, and India, Agilisium is poised to lead the next era
of innovation.
Adding to this, Mr.
Raj Babu said “Agilisium with our
commitment to creating measurable business impact, is not just solving problems
but enabling Life Sciences organizations to reimagine how they innovate, serve
patients, and scale sustainably through Autonomous Agentic AI. With a strong
global footprint and deep domain partnerships, we are poised to lead the next
era of transformation in the industry”.
About Agilisium - Agilisium is the only leading Autonomous
Agentic AI partner for the Life Sciences industry. The company delivers
cutting-edge solutions that drive impactful change by combining strong domain
expertise with GenAI, Autonomous Agentic AI and Advanced Analytics. Agilisium
collaborates with leading pharma and biotech companies to provide hyper
automation of mission-critical business processes, data-driven insights, and
innovative solutions across the value chain, helping accelerate drug discovery,
optimize patient care, achieve commercial success, streamline product delivery,
and foster collaboration. The company’s commitment to rigorous execution and
continuous innovation enables it to shape the future of the Life Sciences
industry.
.jpg)
